Literature DB >> 8089707

GAP-43 and p75NGFR immunoreactivity in presynaptic cells following neuromuscular blockade by botulinum toxin in rat.

S M Hassan1, F G Jennekens, H Veldman, B A Oestreicher.   

Abstract

Peripheral nerve lesion results in changes in protein expression by neurons and denervated Schwann cells. In the present study we have addressed the question whether similar changes take place following functional denervation. Using immunohistochemistry and immunoelectron microscopy we examined changes in growth-associated protein (GAP-43) and low-affinity nerve growth factor receptor (p75NGFR) in rat gastrocnemius muscle following botulinum toxin-induced paralysis. GAP-43 and p75NGFR were selected because they are not expressed by mature intact motor neurons or Schwann cells, but are expressed following nerve lesion in both motor neurons and denervated Schwann cells. In control muscle, GAP-43 and p75NGFR immunoreactivity was seen only in nerve fibres near blood vessels. Two weeks after toxin injection, GAP-43 immunoreactivity could be seen at the motor endplates and in axons. Intensity of staining increased with longer survival and reached a peak between 4 and 8 weeks post-injection. Ultrastructurally, GAP-43 immunoreactivity was confined to nerve terminals and axons, whereas Schwann cells remained negative. Immunostaining for p75NGFR also increased following toxin injection and was detected in some terminal Schwann cells and in perineurial cells of small nerve fascicles near the paralyzed target cells, but not in axons. These results show that changes in expression of GAP-43 in motor neurons following functional denervation closely resemble the changes following anatomical interruption of nerve-muscle contact. GAP-43 was not expressed in Schwann cells, indicating that its upregulation in these cells is induced by loss of axonal contact or nerve degeneration products. There is no support for a role of p75NGFR in incorporation of neurotrophins in axons. The restriction of p75NGFR expression to terminal Schwann cells and perineurial cells in close proximity to the paralyzed target suggests a role for a target-derived signal or, alternatively, macrophages in eliciting this expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089707     DOI: 10.1007/bf01666525

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  7 in total

Review 1.  Neuron-glia interactions: the roles of Schwann cells in neuromuscular synapse formation and function.

Authors:  Yoshie Sugiura; Weichun Lin
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

Review 2.  Perisynaptic Schwann Cells at the Neuromuscular Synapse: Adaptable, Multitasking Glial Cells.

Authors:  Chien-Ping Ko; Richard Robitaille
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

3.  Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.

Authors:  Dario I Carrasco; Ben A Bahr; Kevin L Seburn; Martin J Pinter
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

4.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

5.  Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.

Authors:  Dario I Carrasco; Kevin L Seburn; Martin J Pinter
Journal:  Exp Neurol       Date:  2015-09-26       Impact factor: 5.330

Review 6.  Terminal Schwann Cell Aging: Implications for Age-Associated Neuromuscular Dysfunction.

Authors:  Sandra Fuertes-Alvarez; Ander Izeta
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

7.  Preliminary Study of S100B and Sema3A Expression Patterns in Regenerating Muscle Implicates P75-Expressing Terminal Schwann Cells and Muscle Satellite Cells in Neuromuscular Junction Restoration.

Authors:  Nasibeh Daneshvar; Judy E Anderson
Journal:  Front Cell Dev Biol       Date:  2022-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.